JPRN-jRCT1062230034招募中Unknown
A single-center open-label crossover study of the clinical utility and safety of the BV-UFC system of the DCS-200Si dialysis monitor
Hamada Shintaro0 个研究点目标入组 20 人开始时间: 2023年7月4日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 90age old（—）
- 性别
- All
入选标准
- •(1) Patients who give written consent to participate in this study of their own free will.
- •(2)Hemodialysis patients who are outpatients or inpatients undergoing hemodialysis (regardless of the underlying disease)
- •(3)Patients who are between 20 and 90 years old (regardless of gender) at the time of consent
- •(4)Patients who can be get a blood flow rate of 200 mL/min or more by vascular access
- •(5)Patients who have been receiving hemodialysis for at least 3 months at the time of participation in this study
排除标准
- •Of those who meet the above selection criteria, those who meet any of the following criteria shall not be eligible for enrollment.
- •(1) Patients participating in other clinical research or clinical trials
- •(2)Those who are pregnant
- •(3)Patients who have vascular access recirculation
- •(4) Patients who are deemed by the investigator to be inappropriate to participate in the study.
研究者
相似试验
进行中（未招募）
1 期
ivolumab after selective internal radiation therapy using SIR-Spheres to treat patients with primary liver cancer: a safety and efficacy studyHepatocellular carcinomaEUCTR2017-000232-34-ESClínica Universidad de Navarra/Universidad de Navarra42
未知
1 期
DS-8500a atorvastatin DDI studyHealthy volunteersJPRN-jRCT2080222826DAIICHISANKYO Co.,Ltd.28
已完成
4 期
A multicenter, Single arm, Open label study of The Repeated Administration Of Qutenza For The Treatment Of Peripheral Neuropathic Pain.pain that is caused by damage to the peripheral nervesPeripheral Neuropathic Pain10034606NL-OMON34497Astellas Pharma B.V.12
招募中
3 期
An open-label, single-arm, multicenter study of intracerebral administration of adeno-associated viral vectors serotype rh.10 carrying the human N-sulfoglycosamine sulfohydrolase (SGSH) cDNA for the treatment of mucopolysaccharidosis type IIIA (MPS IIIA)MPS IIISanfilippo syndrome1002742410057167NL-OMON52445ysogene SA10
进行中（未招募）
1 期
A Multicentre, Single-Arm, Open-Label Study Of The Repeated Administration Of QUTENZA For The Treatment Of Peripheral Neuropathic Pain - STRIDEPeripheral Neuropathic Pain in Postherpetic Neuralgia (PHN), Painful HIV-Associated Neuropathy (HIV-AN), Peripheral Neuropathic Injury (PNI), Idiopathic Small Nerve Neuropathy (ISNN) or other Peripheral Neuropathic Pain (PNP).MedDRA version: 12.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2009-016457-18-SKAstellas Pharma Europe Ltd300